P2RX7 (Glu496Ala) mutations in breast cancer patients receiving anthracycline therapy were associated with significantly lower metastasis free survival compared to patients bearing normal P2RX7 alleles [21]. This evidence concerns the gene P2RX7 and breast cancer.